Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism

Clostridium difficile infection (CDI) is caused by a prevalent nosocomial enteric pathogen, leading to high morbidity and mortality. CDI recurrence after antibiotic treatment is high; therefore, it is necessary to develop novel therapeutics against this enteric pathogen. Butyrate is used to treat ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siqi, Xiang, Leyang, li, Fang, Deng, Wenlin, lv, Pinjing, Chen, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434071/
https://www.ncbi.nlm.nih.gov/pubmed/37350595
http://dx.doi.org/10.1128/spectrum.04479-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434071/
https://www.ncbi.nlm.nih.gov/pubmed/37350595
http://dx.doi.org/10.1128/spectrum.04479-22

Ejemplares similares